세계의 병원용 여과 시장 예측(-2030년) : 유형별, 프로세스 유형별, 용도별, 지역별

The hospital filtration market size is projected to grow from USD 2.10 billion in 2024 to USD 3.19 billion by 2030, registering a CAGR of 7.2%. The rise in infections, stringent medical regulations, increased immunocompromised patients and advancements in filtration technology are driving the market for hospital filtration. Also, the huge investment in healthcare, government funding & regulations, and public awareness are propelling the demand. Hospital filtration products play a critical role by ensuring clean & safe environment for patients as well as doctors.

"Point of use filters (POU)to be the fastest growing segment for forecasted period in terms of value."

POU filters are generally used to remove impurities from air and water at the point that it is being used. These filters are installed directly where water and air are being accessed. It works by capturing contaminants as the fluid passes through the filter. This system ensures high level of purification now of use, mainly for very critical applications such as patent care equipment, dialysis machines, surgical procedures and others. It is a very cost-effective system as compared to centralized filtration systems. Its affordability and easy installation make them attractive for healthcare facilities.

"RO System by process type, is projected to be the fastest growing in terms of value."

Reverse osmosis systems are highly efficient in water usage, and produce a high amount of purified water while minimizing waste, which is very crucial in areas facing water scarcity or in industries where water cost is a concern. The high efficiency can lead to high-cost savings over time, both in terms of reduced water intake and lower wastewater treatment expenses. This system contributes positively to environmental sustainability efforts by reducing the volume of wastewater discharged into ecosystems. Due to all these factors, it is very preferred in most of the end-use industries , which drives the demand.

"Europe is estimated to be the second largest in terms of value for the forecasted period."

Europe is the second-largest market for hospital filtration in terms of value due to its well-established healthcare infrastructure, stringent regulatory requirements, and strong focus on infection control. The region's aging population and increasing prevalence of chronic diseases drive the demand for advanced medical care, including the use of high-quality filtration systems to ensure clean and sterile environments. European countries also prioritize sustainability and energy efficiency, leading to the adoption of innovative filtration technologies that align with environmental goals. Furthermore, government initiatives and investments in healthcare advancements, combined with a high awareness of patient safety and healthcare-associated infection (HAI) prevention, contribute to the significant market value in the region.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the hospital filtration market, and information was gathered from secondary research to determine and verify the market size of several segments.

• By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
• By Designation: C Level Executives- 20%, Directors - 10%, and Others - 70%
• By Region: North America - 22%, Europe - 22%, APAC - 45%, ROW -11%

The hospital filtration market comprises major players such as Danaher (US), Veolia (France), Pentair (US), Merck KgaA (Germany), Daikin Industries (Japan), Camfil (Sweden), Freudenberg Technologies (Germany), Solventum (US), Sartorius AG (Germany), and Parker Hannifin Corp. (US). The study includes in-depth competitive analysis of these key players in the hospital filtration market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This report segments the market for hospital filtration market based on type, process type, application, and region, and provides estimations for the overall value of the market across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, products & services, key strategies, new product launches, expansions, and mergers & acquisition associated with the market for hospital filtration market.

Key benefits of buying this report

This research report is focused on various levels of analysis - industry analysis (industry trends), market ranking analysis of top players, and company profiles, which together provide an overall view on the competitive landscape; emerging and high-growth segments of the hospital filtration market; high-growth regions; and market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the hospital filtration market offered by top players in the global hospital filtration market.
• Analysis of drivers: (Growth in healthcare infrastructure, stringent regulations and standards) restraints (High initial investment, maintenance & operational cost), opportunities (Growing demand in emerging markets) and challenges (Integration with existing systems)
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities in the hospital filtration market.
• Market Development: Comprehensive information about lucrative emerging markets - the report analyzes the markets for hospital filtration market across regions.
• Market Capacity: Production capacities of companies producing hospital filtration are provided wherever available with upcoming capacities for the hospital filtration market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the hospital filtration market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 UNITS CONSIDERED
• 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Breakdown of primary interviews
    • 2.1.2.3 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 TOP-DOWN APPROACH
  • 2.2.2 BOTTOM-UP APPROACH
• 2.3 DATA TRIANGULATION
• 2.4 RESEARCH ASSUMPTIONS
• 2.5 RESEARCH LIMITATIONS AND RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN HOSPITAL FILTRATION MARKET
• 4.2 HOSPITAL FILTRATION MARKET, BY TYPE
• 4.3 HOSPITAL FILTRATION MARKET, BY PROCESS TYPE
• 4.4 HOSPITAL FILTRATION MARKET, BY APPLICATION
• 4.5 HOSPITAL FILTRATION MARKET, BY COUNTRY

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Surge in aging population and chronic diseases
    • 5.2.1.2 Increasing investments in healthcare infrastructure
    • 5.2.1.3 Need for high-efficiency filtration systems to prevent spread of infectious diseases
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High initial investments required for hospital filtration systems
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growing demand for filtration in emerging economies
    • 5.2.3.2 Surge in medical tourism and expansion of high-end healthcare facilities
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Integrating modern systems with existing infrastructure
    • 5.2.4.2 Stringent regulations and quality standards
• 5.3 PORTER'S FIVE FORCES ANALYSIS
  • 5.3.1 THREAT OF NEW ENTRANTS
  • 5.3.2 THREAT OF SUBSTITUTES
  • 5.3.3 BARGAINING POWER OF SUPPLIERS
  • 5.3.4 BARGAINING POWER OF BUYERS
  • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.4 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.4.2 BUYING CRITERIA
• 5.5 VALUE CHAIN ANALYSIS
  • 5.5.1 RAW MATERIAL SUPPLIERS
  • 5.5.2 MANUFACTURERS
  • 5.5.3 DISTRIBUTORS
  • 5.5.4 END USERS
• 5.6 ECOSYSTEM ANALYSIS
• 5.7 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.8 PATENT ANALYSIS
  • 5.8.1 METHODOLOGY
  • 5.8.2 DOCUMENT TYPES
  • 5.8.3 PUBLICATION TRENDS
  • 5.8.4 INSIGHTS
  • 5.8.5 JURISDICTION ANALYSIS
  • 5.8.6 TOP APPLICANTS
• 5.9 TRADE ANALYSIS
  • 5.9.1 IMPORT SCENARIO (HS CODE 900220)
  • 5.9.2 EXPORT SCENARIO (HS CODE 900200)
• 5.10 MACROECONOMIC INDICATORS
  • 5.10.1 GLOBAL GDP TRENDS
• 5.11 INVESTMENT AND FUNDING SCENARIO
• 5.12 CASE STUDY ANALYSIS
  • 5.12.1 VEOLIA PROVIDES STATE-OF-THE-ART REVERSE OSMOSIS SYSTEM FOR COSSHAM HOSPITAL'S DIALYSIS UNIT
  • 5.12.2 JAMES PAGET UNIVERSITY HOSPITAL TO IMPLEMENT HIGH-RECOVERY RO SYSTEM TO REDUCE CARBON EMISSIONS AND OPERATIONAL COSTS
  • 5.12.3 UK-BASED HOSPITAL SEEKS RENAL WATER TREATMENT SYSTEM FOR INFECTION CONTROL
• 5.13 REGULATORY LANDSCAPE
  • 5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.14 TECHNOLOGY ANALYSIS
  • 5.14.1 KEY TECHNOLOGIES
    • 5.14.1.1 HEPA 2.0 and ULPA filtration
    • 5.14.1.2 Electrostatic filters
  • 5.14.2 COMPLEMENTARY TECHNOLOGIES
    • 5.14.2.1 Ultraviolet germicidal irradiation
    • 5.14.2.2 Negative pressure rooms
  • 5.14.3 ADJACENT TECHNOLOGIES
    • 5.14.3.1 Airflow management systems
• 5.15 PRICING ANALYSIS
  • 5.15.1 AVERAGE SELLING PRICE TREND, BY REGION, 2021-2030
  • 5.15.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TYPE, 2023
  • 5.15.3 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION, 2023
• 5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.17 IMPACT OF AI ON HOSPITAL FILTRATION MARKET

6 HOSPITAL FILTRATION MARKET, BY TYPE

• 6.1 INTRODUCTION
• 6.2 POINT-OF-USE FILTERS
  • 6.2.1 WIDE USAGE IN AIR AND WATER TREATMENT FOR CRITICAL APPLICATIONS TO DRIVE MARKET
• 6.3 INLINE FILTERS
  • 6.3.1 EASE OF INSTALLATION AND SPACE-SAVING DESIGN TO PROPEL DEMAND
• 6.4 STANDALONE FILTRATION UNITS
  • 6.4.1 LOW INITIAL INVESTMENT AND INSTALLATION COST TO DRIVE GROWTH
• 6.5 OTHER TYPES

7 HOSPITAL FILTRATION MARKET, BY PROCESS TYPE

• 7.1 INTRODUCTION
• 7.2 HEPA
  • 7.2.1 STRINGENT REGULATIONS REGARDING AIR QUALITY IN HOSPITALS TO DRIVE DEMAND
• 7.3 REVERSE OSMOSIS
  • 7.3.1 DEMAND FOR HIGH-PURITY WATER FOR VARIOUS APPLICATIONS TO DRIVE MARKET
• 7.4 ULTRAFILTRATION
  • 7.4.1 WIDE USAGE IN MEDICAL PROCESSES TO DRIVE ADOPTION
• 7.5 GAS FILTRATION
  • 7.5.1 NEED TO MAINTAIN STERILE ENVIRONMENT IN MEDICAL FACILITIES TO DRIVE MARKET
• 7.6 OTHER PROCESS TYPES

8 HOSPITAL FILTRATION MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 HOSPITAL FACILITIES
  • 8.2.1 NEED TO MAINTAIN HIGH STANDARDS FOR AIR AND WATER QUALITY TO DRIVE MARKET
• 8.3 LABORATORIES
  • 8.3.1 RISING DEMAND TO MAINTAIN WATER PURITY STANDARDS TO DRIVE MARKET GROWTH
• 8.4 PATIENT CARE EQUIPMENT
  • 8.4.1 NEED FOR INFECTION CONTROL, PATIENT SAFETY, AND REGULATORY COMPLIANCE TO DRIVE ADOPTION
• 8.5 STERILE ENVIRONMENTS
  • 8.5.1 INCREASED INVESTMENTS BY HOSPITALS IN ADVANCED FILTRATION TECHNOLOGIES TO PROPEL MARKET
• 8.6 OTHER APPLICATIONS

9 HOSPITAL FILTRATION MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 US
    • 9.2.1.1 Growing aging population to drive market
  • 9.2.2 CANADA
    • 9.2.2.1 Rapidly aging population to support market growth
  • 9.2.3 MEXICO
    • 9.2.3.1 Rising healthcare expenditure to drive market
• 9.3 EUROPE
  • 9.3.1 GERMANY
    • 9.3.1.1 High investment in healthcare industry to drive market
  • 9.3.2 FRANCE
    • 9.3.2.1 Aging population to support market growth
  • 9.3.3 SPAIN
    • 9.3.3.1 Ongoing hospital expansion projects to propel market
  • 9.3.4 UK
    • 9.3.4.1 High investments in healthcare sector to drive market
  • 9.3.5 ITALY
    • 9.3.5.1 Increasing investments in upgradation of medical facilities to drive market
  • 9.3.6 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 CHINA
    • 9.4.1.1 Rapidly expanding healthcare industry to propel market
  • 9.4.2 INDIA
    • 9.4.2.1 Government investments and initiatives to drive market
  • 9.4.3 JAPAN
    • 9.4.3.1 Aging population and government-backed initiatives to drive market
  • 9.4.4 SOUTH KOREA
    • 9.4.4.1 Aging population to drive market
  • 9.4.5 REST OF ASIA PACIFIC
• 9.5 MIDDLE EAST & AFRICA
  • 9.5.1 GCC COUNTRIES
    • 9.5.1.1 Saudi Arabia
      • 9.5.1.1.1 Strong government focus on healthcare sector to drive market
    • 9.5.1.2 Rest of GCC Countries
  • 9.5.2 SOUTH AFRICA
    • 9.5.2.1 Continuous investments in infrastructure to boost market growth
  • 9.5.3 REST OF MIDDLE EAST & AFRICA
• 9.6 SOUTH AMERICA
  • 9.6.1 BRAZIL
    • 9.6.1.1 Increasing investments in healthcare and hospital infrastructure to drive market
  • 9.6.2 ARGENTINA
    • 9.6.2.1 Growing aging population to drive market
  • 9.6.3 REST OF SOUTH AMERICA

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
• 10.3 REVENUE ANALYSIS
• 10.4 MARKET SHARE ANALYSIS, 2023
  • 10.4.1 PENTAIR
  • 10.4.2 VEOLIA
  • 10.4.3 DAIKIN
  • 10.4.4 CAMFIL
  • 10.4.5 FREUDENBERG FILTRATION TECHNOLOGIES GMBH & CO. KG
• 10.5 COMPANY VALUATION AND FINANCIAL METRICS
• 10.6 BRAND/PRODUCT COMPARISON ANALYSIS
• 10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 10.7.1 STARS
  • 10.7.2 EMERGING LEADERS
  • 10.7.3 PERVASIVE PLAYERS
  • 10.7.4 PARTICIPANTS
  • 10.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 10.7.5.1 Company footprint
    • 10.7.5.2 Application footprint
    • 10.7.5.3 Process type footprint
    • 10.7.5.4 Region footprint
• 10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 10.8.1 PROGRESSIVE COMPANIES
  • 10.8.2 RESPONSIVE COMPANIES
  • 10.8.3 DYNAMIC COMPANIES
  • 10.8.4 STARTING BLOCKS
  • 10.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 10.8.5.1 Detailed list of key startups/SMEs
    • 10.8.5.2 Competitive benchmarking of key startups/SMEs
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 DEALS
  • 10.9.2 EXPANSIONS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 DANAHER
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products/Solutions/Services offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Deals
      • 11.1.1.3.2 Expansions
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Key strengths
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses and competitive threats
  • 11.1.2 VEOLIA
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products/Solutions/Services offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Deals
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Key strengths
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses and competitive threats
  • 11.1.3 PENTAIR
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products/Solutions/Services offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Deals
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Key strengths
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses and competitive threats
  • 11.1.4 MERCK KGAA
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products/Solutions/Services offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Expansions
    • 11.1.4.4 MnM view
      • 11.1.4.4.1 Key strengths
      • 11.1.4.4.2 Strategic choices
      • 11.1.4.4.3 Weaknesses and competitive threats
  • 11.1.5 DAIKIN INDUSTRIES
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products/Solutions/Services offered
    • 11.1.5.3 Recent developments
      • 11.1.5.3.1 Deals
    • 11.1.5.4 MnM view
      • 11.1.5.4.1 Key strengths
      • 11.1.5.4.2 Strategic choices
      • 11.1.5.4.3 Weaknesses and competitive threats
  • 11.1.6 CAMFIL
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products/Solutions/Services offered.
    • 11.1.6.3 Recent developments
      • 11.1.6.3.1 Expansions
    • 11.1.6.4 MnM view
      • 11.1.6.4.1 Key strengths
      • 11.1.6.4.2 Strategic choices
      • 11.1.6.4.3 Weaknesses and competitive threats
  • 11.1.7 FREUDENBERG FILTRATION TECHNOLOGIES GMBH & CO.KG
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products/Solutions/Services offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Expansions
    • 11.1.7.4 MnM view
  • 11.1.8 SOLVENTUM (3M)
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products/Solutions/Services offered
    • 11.1.8.3 MnM view
  • 11.1.9 SARTORIUS AG
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products/Solutions/Services offered
    • 11.1.9.3 Recent developments
      • 11.1.9.3.1 Expansions
    • 11.1.9.4 MnM view
  • 11.1.10 PARKER HANNIFIN CORP
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products/Solutions/Services offered
    • 11.1.10.3 MnM view
  • 11.1.11 DONALDSON COMPANY, INC.
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products/Solutions/Services offered
    • 11.1.11.3 MnM view
  • 11.1.12 MANN+HUMMEL
    • 11.1.12.1 Business overview
    • 11.1.12.2 Products/Solutions/Services offered
    • 11.1.12.3 Recent developments
      • 11.1.12.3.1 Deals
    • 11.1.12.4 MnM view
  • 11.1.13 DUPONT
    • 11.1.13.1 Business overview
    • 11.1.13.2 Products/Solutions/Services offered
    • 11.1.13.3 MnM view
• 11.2 OTHER PLAYERS
  • 11.2.1 HOLLINGSWORTH & VOSE
  • 11.2.2 FILEDER FILTER SYSTEMS LTD.
  • 11.2.3 COBETTER
  • 11.2.4 NEPHROS
  • 11.2.5 OMNIPURE
  • 11.2.6 DYNA FILTERS
  • 11.2.7 APC FILTRATION INC.
  • 11.2.8 DELTRIAN
  • 11.2.9 GULF AIR FILTRATION COMPANY
  • 11.2.10 COMPLETE WATER SOLUTIONS
  • 11.2.11 FLIER'S QUALITY WATER SYSTEMS, INC.
  • 11.2.12 AHLSTROM

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS